Who
Sian Bigora
Chief Development Officer
Company insider
Files Form 4 as: Chief Development Officer, Processa Pharmaceuticals.
In numbers
- Trades disclosed
- 46
- Buys
- 4
- Sells
- 0
- Bought
- $43K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 8 Jun 2021
- Last trade
- 30 Apr 2026
- Last filed
- 19 May 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Apr 2026filed 19 May 2026 | PCSA Processa PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $5,3411,971 at $2.71 | filing |
| 30 Apr 2026filed 19 May 2026 | PCSA Processa PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $5,3411,971 at $2.71 | filing |
| 30 Apr 2026filed 1 May 2026 | PCSA Processa PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $5,3421,986 at $2.69 | filing |
| 30 Apr 2026filed 1 May 2026 | PCSA Processa PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $5,3421,986 at $2.69 | filing |
| 15 Apr 2026filed 17 Apr 2026 | PCSA Processa PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $5,3431,799 at $2.97 | filing |
| 15 Apr 2026filed 17 Apr 2026 | PCSA Processa PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $5,3431,799 at $2.97 | filing |
| 31 Mar 2026filed 1 Apr 2026 | PCSA Processa PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $5,3412,107 at $2.54 | filing |
| 31 Mar 2026filed 1 Apr 2026 | PCSA Processa PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $5,3522,107 at $2.54 | filing |
| 1 Jan 2026filed 4 Feb 2026 | PCSA Processa PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —249 at $0.00 | filing |
| 1 Jan 2026filed 4 Feb 2026 | PCSA Processa Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —249 at $0.00 | filing |
| 1 Jan 2026filed 4 Feb 2026 | PCSA Processa Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —249 at $0.00 | filing |
| 1 Jan 2026filed 4 Feb 2026 | PCSA Processa PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —249 at $0.00 | filing |
| 1 Oct 2025filed 3 Oct 2025 | PCSA Processa Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —96,000 at $0.00 | filing |
| 1 Oct 2025filed 3 Oct 2025 | PCSA Processa Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —288,000 at $0.00 | filing |
| 24 Jul 2025filed 28 Jul 2025 | PCSA Processa Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,659,185 at $0.00 | filing |
| 1 Apr 2025filed 11 Apr 2025 | PCSA Processa PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —15,059 | filing |
| 1 Apr 2025filed 11 Apr 2025 | PCSA Processa PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $1,3583,311 at $0.41 | filing |
| 10 Jul 2024filed 2 Aug 2024 | PCSA Processa PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —644 | filing |
| 10 Jul 2024filed 2 Aug 2024 | PCSA Processa PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $385225 at $1.71 | filing |
| 28 Jun 2024filed 2 Aug 2024 | PCSA Processa Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,233 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.